{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:06:13Z","timestamp":1784275573897,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009667","name":"School of Medicine, Kyorin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"DOI":"10.1007\/s10633-026-10132-8","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:30:49Z","timestamp":1784273449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Electronegative ERG in association with probable TRPM1-related cancer associated retinopathy: a case report"],"prefix":"10.1007","author":[{"given":"Ryunosuke","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-2607","authenticated-orcid":false,"given":"Hiroshi","family":"Keino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"10132_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/IAE.0000000000000119","volume":"34","author":"DS Grewal","year":"2014","unstructured":"Grewal DS, Fishman GA, Jampol LM (2014) Autoimmune retinopathy and antiretinal antibodies: a review. Retina 34:827\u2013845","journal-title":"Retina"},{"key":"10132_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12886-018-0948-2","volume":"18","author":"F Hoogewoud","year":"2018","unstructured":"Hoogewoud F, Butori P, Blanche P, Brezin AP (2018) Cancer-associated retinopathy preceding the diagnosis of cancer. BMC Ophthalmol 18:285","journal-title":"BMC Ophthalmol"},{"key":"10132_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/0002-9394(76)90125-2","volume":"81","author":"RA Sawyer","year":"1976","unstructured":"Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606\u2013613","journal-title":"Am J Ophthalmol"},{"key":"10132_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJM198912073212307","volume":"321","author":"CE Thirkill","year":"1989","unstructured":"Thirkill CE, FitzGerald P, Sergott RC, Roth AM, Tyler NK, Keltner JL (1989) Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med 321:1589\u20131594","journal-title":"N Engl J Med"},{"key":"10132_CR5","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.4103\/ijo.IJO_786_20","volume":"68","author":"P Dutta Majumder","year":"2020","unstructured":"Dutta Majumder P, Marchese A, Pichi F, Garg I, Agarwal A (2020) An update on autoimmune retinopathy. Indian J Ophthalmol 68:1829\u20131837","journal-title":"Indian J Ophthalmol"},{"key":"10132_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10633-007-9074-9","volume":"116","author":"G Goetgebuer","year":"2008","unstructured":"Goetgebuer G, Kestelyn-Stevens AM, De Laey JJ, Kestelyn P, Leroy BP (2008) Cancer-associated retinopathy (CAR) with electronegative ERG: a case report. Doc Ophthalmol 116:49\u201355","journal-title":"Doc Ophthalmol"},{"key":"10132_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10633-017-9605-y","volume":"135","author":"D Roels","year":"2017","unstructured":"Roels D, Ueno S, Talianu CD, Draganova D, Kondo M, Leroy BP (2017) Unilateral cancer-associated retinopathy: diagnosis, serology and treatment. Doc Ophthalmol 135:233\u2013240","journal-title":"Doc Ophthalmol"},{"key":"10132_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019911","volume":"6","author":"M Kondo","year":"2011","unstructured":"Kondo M, Sanuki R, Ueno S et al (2011) Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS ONE 6:e19911","journal-title":"PLoS ONE"},{"key":"10132_CR9","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1097\/IAE.0000000000002329","volume":"39","author":"S Ueno","year":"2019","unstructured":"Ueno S, Inooka D, Nakanishi A et al (2019) Clinical course of paraneoplastic retinopathy with anti-TRPM1 autoantibody in Japanese cohort. Retina 39:2410\u20132418","journal-title":"Retina"},{"key":"10132_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ajhg.2009.10.003","volume":"85","author":"Z Li","year":"2009","unstructured":"Li Z, Sergouniotis PI, Michaelides M, Mackay DS, Wright GA, Devery S, Moore AT, Holder GE, Robson AG, Webster AR (2009) Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans. Am J Hum Genet 85:711\u2013719","journal-title":"Am J Hum Genet"},{"key":"10132_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/ceo.14065","volume":"50","author":"DH Sakti","year":"2022","unstructured":"Sakti DH, Ali H, Korsakova M, Saakova N, Mustafic N, Fraser CL, Jamieson RV, Cornish EE, Grigg JR (2022) Electronegative electroretinogram in the modern multimodal imaging era. Clin Exp Ophthalmol 50:429\u2013440","journal-title":"Clin Exp Ophthalmol"},{"key":"10132_CR12","doi-asserted-by":"crossref","unstructured":"Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M, Li S, McCulloch DL (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144:165\u2013177.","DOI":"10.1007\/s10633-022-09872-0"},{"key":"10132_CR13","doi-asserted-by":"publisher","first-page":"19174","DOI":"10.1073\/pnas.0908711106","volume":"106","author":"CW Morgans","year":"2009","unstructured":"Morgans CW, Zhang J, Jeffrey BG et al (2009) TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc Natl Acad Sci USA 106:19174\u201319178","journal-title":"Proc Natl Acad Sci USA"},{"key":"10132_CR14","first-page":"262","volume":"41","author":"B Lei","year":"2000","unstructured":"Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41:262\u2013266","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10132_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108770","volume":"212","author":"D Gyoten","year":"2021","unstructured":"Gyoten D, Ueno S, Okado S et al (2021) Broad locations of antigenic regions for anti-TRPM1 autoantibodies in paraneoplastic retinopathy with retinal ON bipolar cell dysfunction. Exp Eye Res 212:108770","journal-title":"Exp Eye Res"},{"key":"10132_CR16","first-page":"6607441","volume":"2021","author":"Y Shinohara","year":"2021","unstructured":"Shinohara Y, Mukai R, Ueno S, Akiyama H (2021) Clinical findings of melanoma-associated retinopathy with anti-TRPM1 antibody. Case Rep Ophthalmol Med 2021:6607441","journal-title":"Case Rep Ophthalmol Med"},{"key":"10132_CR17","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1167\/iovs.11-7575","volume":"52","author":"J Klooster","year":"2011","unstructured":"Klooster J, Blokker J, Ten Brink JB et al (2011) Ultrastructural localization and expression of TRPM1 in the human retina. Invest Ophthalmol Vis Sci 52:8356\u20138362","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10132_CR18","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1167\/iovs.17-21443","volume":"58","author":"RM Duvoisin","year":"2017","unstructured":"Duvoisin RM, Haley TL, Ren G, Strycharska-Orczyk I, Bonaparte JP, Morgans CW (2017) Autoantibodies in melanoma-associated retinopathy recognize an epitope conserved between TRPM1 and TRPM3. Invest Ophthalmol Vis Sci 58:2732\u20132738","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10132_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.survophthal.2012.09.001","volume":"58","author":"E Rahimy","year":"2013","unstructured":"Rahimy E, Sarraf D (2013) Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol 58:430\u2013458","journal-title":"Surv Ophthalmol"},{"key":"10132_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.oret.2023.05.002","volume":"7","author":"N Brossard-Barbosa","year":"2023","unstructured":"Brossard-Barbosa N, Dezard V, Margolin E (2023) Treatment of cancer-associated retinopathy: a systematic literature review. Ophthalmol Retina 7:819\u2013828","journal-title":"Ophthalmol Retina"},{"key":"10132_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00041327-200109000-00004","volume":"21","author":"JL Keltner","year":"2001","unstructured":"Keltner JL, Thirkill CE, Yip PT (2001) Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21:173\u2013187","journal-title":"J Neuroophthalmol"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-026-10132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-026-10132-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-026-10132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:30:51Z","timestamp":1784273451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-026-10132-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":21,"alternative-id":["10132"],"URL":"https:\/\/doi.org\/10.1007\/s10633-026-10132-8","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Hiroshi Keino: Research grants from Alcon Laboratories, Inc. Honorarium from AbbVie GK, Santen Pharmaceutical Co, Mitsubishi Tanabe Pharma, Chugai, Bayer Yakuhin Ltd., Senju Pharmaceutical Co., Ltd., Novartis Pharma KK. Makoto Inoue: Research grants from Santen Pharmaceutical Co., Alcon Laboratories, Inc., and SENJU Pharmaceutical Co., Ltd. Consulting fees from HOYA, Carl Zeiss Meditec AG, and Alcon Laboratories, Inc. Honorarium from Novartis Pharma, Bayer, Chugai, Carl Zeiss Meditec AG, Logic & Design Inc, Santen Pharmaceutical Co., SENJU Pharmaceutical Co., Ltd., Alcon Laboratories, Inc., AMO, and HOYA.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval for this study was obtained from the Ethics Committee of Kyorin University School of Medicine (Ethics approval No: 736).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent regarding publishing data was obtained from the participant included in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}